Answers are grounded in this paper and cite their sources.
Immune homeostasis is crucial for health, yet its hyperactivation or suppression poses significant therapeutic challenges. Nanocatalysts, especially transition metal-based nanocatalysts, are powerful chemical tools for immunomodulation. They work by precisely regulating chemical species in pathological microenvironments. These nanocatalysts serve two therapeutic purposes. First, antioxidative nanocatalysts scavenge excess ROS. This "cools down" hyperactivated immunity in inflammatory diseases, such as cardiovascular disorders, neuroinflammation, and bone diseases. Second, pro-oxidative nanocatalysts generate ROS. This "heats up" suppressed immunity in cancer and infections, mainly by inducing immunogenic cell death. This tutorial review elucidates the chemical basis of nanocatalytic bidirectional immunomodulation, discussing related catalytic and therapeutic mechanisms based on typical paradigms. Rational design of nanocatalysts determines which chemical reactions occur. These reactions lead to different immunoregulatory outcomes. Nanocatalytic bidirectional immunomodulation provides a richer set of chemical tools to meet the requirements of immune activation or suppression during disease treatments. Most existing reviews have focused on unidirectional nanocatalytic therapy. This tutorial review is the first work to systematically unify nanocatalytic anti-inflammation and nanocatalytic immunotherapy from the perspective of "bidirectional immunomodulation".
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: